Could a quick quiz end millions of unnecessary penicillin allergies?
NCT ID NCT05464615
First seen Jul 17, 2026 · Last updated Jul 21, 2026 · Updated 2 times
Summary
This study tests whether a short questionnaire can identify hospitalized patients who were incorrectly labeled as allergic to penicillin. Those deemed low-risk receive a supervised dose of amoxicillin to confirm they can tolerate it. If they do, the allergy label is removed from their medical records, potentially improving their future treatment options.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- amoxicillin
- What this could lead to
- If successful, this approach could safely remove penicillin allergy labels for many hospitalized patients, allowing them to receive more effective antibiotics.
- What could go wrong
- This is a small early-phase study, and the questionnaire may not accurately identify all low-risk patients, leading to allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PENICILLIN ALLERGY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Geisinger Community Medical Center
Scranton, Pennsylvania, 18510, United States
-
Geisinger Lewistown Hospital
Lewiston, Pennsylvania, 17044, United States
-
Geisinger Medical Center
Danville, Pennsylvania, 17822, United States
-
Geisinger Wyoming Valley
Wilkes-Barre, Pennsylvania, 18711, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.